RecruitingNot ApplicableNCT04998188

Hydrolyzed Collagen Formulation vs Placebo in Knee Osteoarthritis

Hydrolyzed Collagen Formulation Versus Placebo in the Treatment of Degenerative Knee Cartilage Injuries


Sponsor

Istituto Ortopedico Rizzoli

Enrollment

204 participants

Start Date

Feb 16, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to compare the 6 months clinical outcome of the treatment with a single intra-articular collagen injection versus a single placebo (saline solution) infiltration in the infiltrative treatment of knee osteoarthritis. The evaluation will be performed through clinical, subjective and objective assessments.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Collagen and a procedure called Placebo (saline solution) for people with knee osteoarthritis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECollagen

Patients will be treated with a single injection of collagen (2 ml) in the knee joint affected by osteoarthritis

PROCEDUREPlacebo (saline solution)

Patients will be treated with a single injections of saline solution (2 ml) in the knee joint affected by osteoarthritis


Locations(1)

Istituto Ortopedico Rizzoli

Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04998188


Related Trials